Standout Papers
- Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer (2000)
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study (2008)
- Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer (2008)
- Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients (2000)
Immediate Impact
4 by Nobel laureates 5 from Science/Nature 127 standout
Citing Papers
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Works of Jim Cassidy being referenced
Disease Course Patterns After Discontinuation of Bevacizumab: Pooled Analysis of Randomized Phase III Trials
2010
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
2000 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jim Cassidy | 9224 | 3003 | 1500 | 2316 | 122 | 11.5k | |
| C. Boni | 10741 | 5397 | 2106 | 1682 | 118 | 13.6k | |
| Alberto Sobrero | 9402 | 3787 | 2287 | 2619 | 199 | 11.8k | |
| Jean A. Maroun | 7313 | 2591 | 1649 | 1370 | 135 | 9.4k | |
| Matilde Navarro | 7992 | 2162 | 2061 | 1586 | 72 | 9.7k | |
| Michel Seymour | 8914 | 3523 | 2702 | 1908 | 230 | 12.1k | |
| H. Cortés-Funes | 6339 | 2601 | 858 | 1006 | 187 | 9.4k | |
| Eduardo Díaz‐Rubio | 8527 | 3438 | 1885 | 1963 | 353 | 11.8k | |
| Arié Figer | 11366 | 3967 | 1870 | 3328 | 105 | 14.3k | |
| Tamas Hickish | 9922 | 4218 | 2234 | 915 | 142 | 13.2k | |
| Christophe Tournigand | 6781 | 2921 | 1208 | 1971 | 254 | 9.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...